SK bioscience wins patent case against Moderna in South Korea
SK bioscience, the biopharmaceutical arm of South Korea’s SK Group, said on Wednesday it has achieved a “final victory” in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity suit in 2023 challenging Moderna’s patent on modified nucleosides, nucleotides and nucleic acids, as well … Read more